Background: This study aimed to assess the nationwide trends in optimal diabetic care and complications of elderly type 2 diabetes mellitus (T2DM) patients over a 6-year period in Thailand.
INTRODUCTION
Type 2 diabetes mellitus (T2DM) is increasing in prevalence, contributed mainly by the aging populations worldwide. [1] [2] [3] The proportion of Asian populations over 65 years of age had increased significantly from 7.7% in 2005 to 10.1% in 2014. 4 Projections suggest that the elderly age proportion will continue to increase from 10.5% in 2015 to 26.6% and 32.1% in 2030 and 2040, respectively. 5 Thailand is classified as a developing country with an upper middle income level. 6 Consistent with all other countries worldwide, Thailand has also had T2DM is a major healthcare burden worldwide. 1, 7, 8 Among the Thai population, it is responsible for 3.3% and 8.2% of total deaths in male and females, respectively. 9 One study found that older age was a significant predictor of higher healthcare costs among diabetic patients in Thailand. 9 The prevalence of older individuals over 65 years old with T2DM in Thailand reached 17.2% as reported by the InterASIA study in 2003. 10 Universal health coverage scheme (UCS) was launched in Thailand in 2001. 11, 12 This is a public health insurance system that aims to provide universal access to medical care, which includes essential medications, primary care, and hospital care. Resources must be used efficiently in the setting of capitated payments and the increasing aging population. Evaluations of the long-term impacts of universal health coverage on health care for elderly diabetic patients are urgently needed. However, data on diabetic control and complications in this group are limited by the heterogeneity of the aging process. Thus, the aim of this study was to determine the nationwide trends in optimal diabetic care and complications of elderly T2DM patients over a 6-year period in Thailand. of sample collection was the hospitals' levels, which were stratified into five strata by their size in each province. These five strata were regional (>500 beds), provincial (200-500 beds), large community (80-120 beds), medium community (60 beds), and small community hospitals (10-30 beds). All regional (n = 25) and provincial (n = 70) hospitals were enrolled but only 62% (456 out of 736) community hospitals were included. Of 456 community hospitals, 10%, 20%, and 70% were large, medium and small community hospitals, respectively. Well- 
MATERIALS AND METHODS

Study population
T2DM care and complications
The optimal T2DM care in elderly patients was defined as: (1) blood pressure (BP) < 140/90 mm Hg, [13] [14] [15] (2) hemoglobin A1C (HbA1c) < 7%, 16 ,17 (3) low-density lipoprotein cholesterol (LDL-C) < 100 mg/dL, 16 (4) use of antiplatelet medications, 15, 16 and (5) use of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) in hypertensive patients. 15, 16 T2DM treatment-related complications included hospital admissions due to dysglycemia (either hypo-or hyperglycemia). 14 T2DM-related complications included coronary artery disease (CAD), stroke, peripheral artery disease (PAD), chronic kidney disease (CKD), diabetic retinopathy (DR), diabetic foot ulcer, and lower extremity amputation. Estimated glomerular filtration rate (eGFR) was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) creatinine equation. 18 CKD was defined as eGFR of less than 60 mL/min/1.73 m 2 .
Statistical analysis
Continuous variables were reported as mean ± SD. Categorical variables were reported as counts and percentages. The linear trends in the optimal management of T2DM, T2DM-related complications, and T2DM treatment-related complications in each year from 2010 through 2015 were graphically presented and tested using orthogonal polynomial contrasts. P values of less than 0.05 were considered statistically significant. All statistical analyses were performed using SPSS (version 22.0, IBM Corporation, Armonk, NY, USA). patients (P for trend < 0.001) ( Table 2 and Figure 2 ).
RESULTS
Clinical characteristics
Trends in optimal T2DM care and T2DM treatment-related complications
Trends in prevalence of T2DM-related complications
Out of 54 295 elderly T2DM patients, the prevalence of CAD was 3817 (7.0%), stroke was 1623 (3.0%), PAD was 274 (0.5%), DR was 3298 (6.1%), CKD was 30 228 (55.7%), diabetic foot ulcer was 1317 (2.4%), and lower limb amputation was 154 (0.3%). From 2010 to 2015, there was an increasing trend in prevalence of CAD, stroke, and PAD (P for trend < 0.001). There was a decreasing trend in prevalence of CKD, diabetic foot ulcer, and lower limb amputation (P for trend < 0.001).
DR did not change (Table 3 and Figure 3 ).
DISCUSSION
This was a large nationwide, multicenter study that examined trends in T2DM care and diabetes-related complications among elderly dia- and LDL-C among elderly T2DM patients, hospital admissions due to dysglycemia decreased significantly over the study period.
This study showed that the percentage of patients over 65 years old has increased, consistent with two related reports by Beard et al. 19 and Sloan et al. 20 The combination of increased insulin resistance and impaired insulin secretion in elderly diabetics is considered the main pathophysiologic mechanism. 21 Multiple factors associated with advancing age, such as adiposity, sarcopenia and physical inactivity 22 can contribute to insulin resistance. While older adults tend to have normal hepatic glucose output, aging is also correlated with declining pancreatic islet cell function and lower insulin levels. 23 Elderly patients with T2DM can be divided into two subgroups: elderly onset (or senile diabetes) and long-standing diabetes (or younger age at onset) groups. 21 Those who developed T2DM in old age are more likely to have near normal fasting glucose levels but significant postprandial hyperglycemia. 24 In contrast to the elderly onset diabetes, long-standing diabetic elderly patients tend to develop more diabetic complications. This present study suggests that the prevalence of longstanding diabetes has increased. The number of elderly patients with long-standing diabetes is expected to grow as the population ages. [1] [2] [3] The impact of achieving treatment targets 13, 15, 16, 23, [25] [26] [27] regardless of their age and comorbidities. 33 With this new classification, the crude prevalence of hypertension will increase and at least 75% of elderly patients aged ≥65 years are now hypertensive. 34 Future prospective studies are required to assess the percentage of T2DM elderly patients who can achieve this stricter BP goal and the associated outcomes. between 6% and 9%. 35 Additionally, randomized controlled trials have subsequently shown no beneficial effects of intensive glucose control on all-cause mortality among T2DM elderly patients. [36] [37] [38] [39] [40] [41] [42] These findings have thus resulted in less intense treatment targets worldwide compared to "conventional" glucose control targets. 43, 44 Current Thailand diabetic guidelines for healthy elderly patients suggest HbA1c of less than 7%, 16 similar to the Canadian guidelines. 45 Other published guidelines are less intensive: the European 46 and the International Diabetes Federation global guidelines suggest HbA1c goal of 7-7.5% 17 and the American Diabetes Association suggests HbA1c of less than 7.5%. 14 The recent HbA1c guideline changes and our study's trend in decreased achievement of HbA1c <7% may account for the decreased prevalence of dysglycemic Thailand hospital admissions due to less hypoglycemic complications, similar to the trend in developed countries. 47, 48 From a policy perspective, hypoglycemia has been proposed as a key adverse drug event and utilized as a performance measure for healthcare systems worldwide. 49 The percentage of Thai elderly patients with T2DM who achieved the target level of LDL < 100 mg/dL was also decreasing despite a worldwide increasing trend in statin use for both primary and secondary prevention for all patients. 50 The underlying explanation for the decrease in LDL control is unclear. Medical practitioners may perceive decreased benefit versus risk from statin use in the elderly due to lower predicted life expectancy, polypharmacy, or a higher risk for statin-induced toxicity such as rhabdomyolysis or hepatitis. The beneficial effects of lowering LDL level among elderly patients with diabetic
TA B L E 3 Trend in prevalence of T2DM-related complications
CAD cannot be ascertained from this study due to the limitation of the design.
The proportions of study patients receiving antiplatelets and ACEI/ARB have increased, similar to other study findings. 28 The prevalence trend for microvascular complications (CKD or DR) declined over the 6-year study period. The prevalence of CKD in our study was also consistent with another related report from the United States. 51 The decreasing trend of CKD might have thus resulted from improving BP control and increasing ACEI/ARB use in elderly diabetes. Treatment of hypertension has been shown to be very effective in preventing and delaying CKD among elderly diabetic patients with hypertension. 52 Renin angiotensin aldosterone blockers, such as ACEI and ARB, additionally slow the progression of diabetic kidney disease in both type 1 and 2 diabetic patients. 53, 54 There are several limitations of this study noted. First, data were retrospectively collected through medical records, and incomplete records may either have a random effect or be associated with provider diligence. Second, the optimal diabetic care goals were not stratified by units and publics hospitals in Thailand. As the result, the finding of this study likely represented the trend in T2DM care of patients at public hospitals in Thailand but might not be generalizable to patients receiving care at primary care units or university hospitals. 
CONCLUSION
In
CONFLICTS OF INTEREST
The authors declare no conflicts of interest.
